RKLB · Rocket Lab Corporation
AI read · Good for RKLB
The AI's read
Rocket Lab replaced its equity distribution agreement to sell up to $1.94 billion of common stock, with proceeds earmarked for the Iridium acquisition and reducing senior secured debt. That clears a key funding question for the deal and lowers reliance on new borrowings. The program is not larger than the prior May agreement; it simply carries forward the same unsold stock. The market barely moved, down ~1%, while RSI sits near 69, so momentum is positive but not frothy. We lean bullish because the raise removes a financing overhang without adding incremental dilution, making the acquisition more viable. Conviction 90%: company-specific catalyst, clear use of proceeds, but market consolidation increases whipsaw risk.